HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Three achieve new posts in Praxis' research. (Peter R. Paradiso, James L. Cowell, Charles W. Finn Jr., Praxis Biologics Inc.)
-
PR Newswire; Aug 30, 1989; 700+ Words
...developer Praxis Biologics, Inc. (NASDAQ...Development; James L. Cowell, Ph...diseases using advanced methods of immunochemistry...in Sanford, N.C. In June, Praxis...Y. --James L. Cowell, with...Washington, D.C.; and Bethesda...
-
-
Susman Godfrey L.L.P. Files Class Action Lawsuit Against Dendreon Corporation On Behalf of Investors - DNDN.
-
PR Newswire; Jun 9, 2007; 700+ Words
...Susman Godfrey L.L.P. (dndn...cancer. Its most advanced product is Provenge...immunotherapy for advanced prostate cancer...the Company's Biologics License Application...Susman Godfrey L.L.P., a firm...Contact: Ryan C. Kirkpatrick...
-
-
AltaRex Grants Purdue Pharma L.P. an Option to License Two Products in a Potential.
-
PR Newswire; May 13, 1999; 700+ Words
...and Purdue Pharma L.P. today announced...regulatory approval, C$5 million of...to approximately C$19.3-million...Purdue Pharma L.P. and its associated...AltaRex's advanced antibody technologies...build world-class biologics and oncology businesses...also includes a biologic ...
-
-
MILLENNIU/BZL BIOLOGICS TO DEVELOP ANTIBODY THERAPIES AGAINST PROSTATE CANCER.
-
AsiaPulse News; Apr 16, 2001; 700+ Words
...Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and BZL Biologics, L.L.C., a privately- held company, today announced they...towards the extracellular domain of PSMA, is the most advanced anti-PSMA antibody in development. In animal models...
-
-
Millennium and BZL Biologics Announce Agreement To Develop Antibody Therapies Against Key Target In Prostate Cancer.
-
PR Newswire; Apr 11, 2001; 700+ Words
...Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and BZL Biologics, L.L.C., a privately- held company, today announced they...towards the extracellular domain of PSMA, is the most advanced anti-PSMA antibody in development. In animal models...
-
-
New hepatocellular cancer in children research reported from L. Montella and co-authors.(Clinical report)
-
Angiogenesis Weekly; Sep 5, 2008; 700+ Words
...frustrating results in advanced HCC especially...Several biologic non-chemotherapeutic...patients affected by advanced HCC (26 M and...patients with Child C compensated cirrhosis...progression," wrote L. Montella and...was active in advanced HCC, however...
-
-
Synta Pharmaceuticals Appoints Matthew L. Sherman, M.D. as Senior Vice President and Chief Medical Officer.
-
PR Newswire; Mar 9, 2004; 700+ Words
...appointment of Matthew L. Sherman, M...Keith S. Ehrlich, C.P.A. as Vice...organization." Matthew L. Sherman, M...small molecule and biologic therapeutics...Keith S. Ehrlich, C.P.A. was previously...with its two most advanced products in Phase...
-
-
Other News To Note.(partnership between Cellumen Inc. and Alzheimer's Drug Discovery Foundation )(research agreement between Cempra Pharmaceuticals Inc. and Biovista Inc.)(Enzon Pharmaceuticals Inc. get approval for L-asparaginase)
-
BIOWORLD Today; Oct 1, 2008; 700+ Words
...Chapel Hill, N.C., and Biovista...generation pegylated L-asparaginase...to manufacture L-asparaginase...data repository, advanced search and statistical...PDUFA date for its biologics license application...Triangle Park, N.C., said it expanded...
-
-
New biologic might help treatment of patients with severe, refractory gout.(Musculoskeletel Disorders)(Clinical report)
-
Family Practice News; Jan 1, 2008; ; 700+ Words
...attaches to and neutralizes IL-l before the proinflammatory...rilonacept is described as an IL-l-specific cytokine trap...levels of high-sensitivity C-reactive protein (hs...said Dr. Terkeltaub. Advanced age, comorbidities such as...
-
-
Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors.
-
PR Newswire; Nov 17, 2009; 700+ Words
...patients with advanced, refractory tumors...patients with advanced solid tumors...Sausville, L. Garbo, G...Yurkovetskiy, C. Bethune, R...patients with advanced solid tumors...small molecules, biologics and nucleic acids...
-
-
Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors.
-
PR Newswire; Jun 1, 2009; 700+ Words
...in patients with advanced solid tumors...to patients with advanced solid tumors." By E. Sausville, L. Garbo, G. J...Yurkovetskiy, C. Bethune, R...Level 2, West Hall C About Fleximer...small molecules and biologics. Fleximer(R...
-
-
Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors.(Financial report)
-
PR Newswire Europe; Jun 1, 2009; 700+ Words
...in patients with advanced solid tumors...to patients with advanced solid tumors." By E. Sausville, L. Garbo, G. J...Yurkovetskiy, C. Bethune, R...Level 2, West Hall C About Fleximer...small molecules and biologics. Fleximer(R...
-
-
Avid Bioservices to Highlight Its Advanced Biomanufacturing and Process Development Capabilities at 2009 BIO International Convention.
-
Business Wire; May 13, 2009; 700+ Words
...of cGMP contract manufacturing of biologics and other key services, today announced...B. technology, installing 100 L and 1000 L S.U.B. systems at its biomanufacturing...clinical programs in cancer and hepatitis C virus infection with its lead product...
-
-
People.(NEWS)
-
Crain's Detroit Business; Apr 20, 2009; 700+ Words
...Hydra Professionals L.L.C., Farmington Hills...Glenn Nixon to director of advanced simulation technologies...initiatives, Core Products Group L.L.C., Livonia, from manager...president of operations, RTI Biologics, Alachua, Fla.; also...
-
-
Dendreon Corporation Reports Third Quarter 2002 Financial Results.
-
Business Wire; Oct 28, 2002; 700+ Words
...amp; Development, L.L.C., and Kirin. The net...enrolled in the trial had advanced prostate cancer and most...Research & Development, L.L.C. and Kirin Brewery Co...support an application for a biologics license, risks that the...
-
-
Researchers Receive $1,886,237 in Funding from NCCN Clinical Trials Network.
-
Business Wire; Feb 20, 2003; 700+ Words
...in Patients with Advanced Colorectal Carcinoma...150,487 -- C. L. Shapiro, Arthur...Cancer Center, "Biologic Markers of Angiogenesis...in Patients with Advanced Malignancies' and...199,975 -- C. L. Shapiro, Arthur...
-
-
Patents.
-
Fairfield County Business Journal; Apr 18, 2005; 700+ Words
...Apparatus for analyzing biologic fluids. 6,869...Walker Digital L.L.C., Stamford. Method...Stamford; Stephen C. Tulley, Fairfield...to Walker Digital L.L.C., Stamford. Method...I., assigned to Advanced Fuel Research Inc...
-
-
APPOINTMENTS
-
The Washington Post; May 1, 1989; 700+ Words
...biotechnology and biologics and Michael Calingaert...will join the D.C. Chamber of Commerce...Springfield named John L. Oliphant Jr. president, Edward L. Fuller first...Maryland-D.C. chapter. BANKING...Jean-Paul Martin advanced applications manager...
-
-
Products & services directory.
-
Feedstuffs; Jul 10, 2002; 700+ Words
...Antibiotics A & L Analytical Labs...Technologies Int'l. Inc. Advanced Microbial Systems...Inc. Biogaia Biologics Inc. Biomin...efficiency agents Advanced Microbial Systems...Alamo S.A. de C.V. Albion...TransAgra Int'l. Inc. Ultralyx...
-
-
Animal health product manufacturers.(Products & Services Directory)(Directory)
-
Feedstuffs; Sep 17, 2003; 700+ Words
...Antibiotics A & L Analytical Labs...Technologies Int'l. Inc. ADM...Nutrition Advanced Microbial Systems...Inc. BioGaia Biologics Inc. Biomin...Nutrition Advanced Microbial Systems...Alamo S.A. de C.V. Altech...TransAgra Int'l. Inc. Ultralyx...
|
|